These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17309913)

  • 1. Impact of left ventricular lead position on the efficacy of cardiac resynchronisation therapy: a two-dimensional strain echocardiography study.
    Becker M; Franke A; Breithardt OA; Ocklenburg C; Kaminski T; Kramann R; Knackstedt C; Stellbrink C; Hanrath P; Schauerte P; Hoffmann R
    Heart; 2007 Oct; 93(10):1197-203. PubMed ID: 17309913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of left ventricular lead position in cardiac resynchronization therapy on left ventricular remodelling. A circumferential strain analysis based on 2D echocardiography.
    Becker M; Kramann R; Franke A; Breithardt OA; Heussen N; Knackstedt C; Stellbrink C; Schauerte P; Kelm M; Hoffmann R
    Eur Heart J; 2007 May; 28(10):1211-20. PubMed ID: 17426079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of optimal lead positioning as defined by three-dimensional echocardiography to long-term benefit of cardiac resynchronization.
    Becker M; Hoffmann R; Schmitz F; Hundemer A; Kühl H; Schauerte P; Kelm M; Franke A
    Am J Cardiol; 2007 Dec; 100(11):1671-6. PubMed ID: 18036367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of LV lead position in cardiac resynchronization therapy using different imaging modalities.
    Becker M; Altiok E; Ocklenburg C; Krings R; Adams D; Lysansky M; Vogel B; Schauerte P; Knackstedt C; Hoffmann R
    JACC Cardiovasc Imaging; 2010 May; 3(5):472-81. PubMed ID: 20466342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dependency of cardiac resynchronization therapy on myocardial viability at the LV lead position.
    Becker M; Zwicker C; Kaminski M; Napp A; Altiok E; Ocklenburg C; Friedman Z; Adam D; Schauerte P; Marx N; Hoffmann R
    JACC Cardiovasc Imaging; 2011 Apr; 4(4):366-74. PubMed ID: 21492811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic benefit of optimum left ventricular lead position in cardiac resynchronization therapy: follow-up of the TARGET Study Cohort (Targeted Left Ventricular Lead Placement to guide Cardiac Resynchronization Therapy).
    Kydd AC; Khan FZ; Watson WD; Pugh PJ; Virdee MS; Dutka DP
    JACC Heart Fail; 2014 Jun; 2(3):205-12. PubMed ID: 24952685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of right ventricular lead location on response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Haghjoo M; Bonakdar HR; Jorat MV; Fazelifar AF; Alizadeh A; Ojaghi-Haghjghi Z; Esmaielzadeh M; Sadr-Ameli MA
    Europace; 2009 Mar; 11(3):356-63. PubMed ID: 19136489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline asynchrony, assessed circumferentially using temporal uniformity of strain, besides coincidence between site of latest mechanical activation and presumed left ventricular lead position, predicts favourable prognosis after resynchronization therapy.
    Cavallino C; Rondano E; Magnani A; Leva L; Inglese E; Dell'era G; Occhetta E; Bortnik M; Marino PN
    Int J Cardiovasc Imaging; 2012 Jun; 28(5):1011-21. PubMed ID: 21688135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Success rate of transvenous left ventricular lead implantation for cardiac resynchronisation therapy - recent experience of a single centre.
    Sterliński M; Maciag A; Kowalik I; Lewandowski M; Zajac D; Syska P; Sosnowski C; Labecka A; Kuśmierski K; Pytkowski M; Szwed H
    Kardiol Pol; 2010 Aug; 68(8):903-9. PubMed ID: 20730721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy.
    Ypenburg C; van Bommel RJ; Delgado V; Mollema SA; Bleeker GB; Boersma E; Schalij MJ; Bax JJ
    J Am Coll Cardiol; 2008 Oct; 52(17):1402-9. PubMed ID: 18940531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial.
    Pouleur AC; Knappe D; Shah AM; Uno H; Bourgoun M; Foster E; McNitt S; Hall WJ; Zareba W; Goldenberg I; Moss AJ; Pfeffer MA; Solomon SD;
    Eur Heart J; 2011 Jul; 32(14):1720-9. PubMed ID: 21609974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive imaging of cardiac venous anatomy with 64-slice multi-slice computed tomography and noninvasive assessment of left ventricular dyssynchrony by 3-dimensional tissue synchronization imaging in patients with heart failure scheduled for cardiac resynchronization therapy.
    Van de Veire NR; Marsan NA; Schuijf JD; Bleeker GB; Wijffels MC; van Erven L; Holman ER; De Sutter J; van der Wall EE; Schalij MJ; Bax JJ
    Am J Cardiol; 2008 Apr; 101(7):1023-9. PubMed ID: 18359325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue synchronization imaging and optimal left ventricular pacing site in cardiac resynchronization therapy.
    Murphy RT; Sigurdsson G; Mulamalla S; Agler D; Popovic ZB; Starling RC; Wilkoff BL; Thomas JD; Grimm RA
    Am J Cardiol; 2006 Jun; 97(11):1615-21. PubMed ID: 16728225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing hemodynamics in heart failure patients by systematic screening of left ventricular pacing sites: the lateral left ventricular wall and the coronary sinus are rarely the best sites.
    Derval N; Steendijk P; Gula LJ; Deplagne A; Laborderie J; Sacher F; Knecht S; Wright M; Nault I; Ploux S; Ritter P; Bordachar P; Lafitte S; Réant P; Klein GJ; Narayan SM; Garrigue S; Hocini M; Haissaguerre M; Clementy J; Jaïs P
    J Am Coll Cardiol; 2010 Feb; 55(6):566-75. PubMed ID: 19931364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar long-term benefits conferred by apical versus mid-septal implantation of the right ventricular lead in recipients of cardiac resynchronization therapy systems.
    Bulava A; Lukl J
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S32-7. PubMed ID: 19250108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular lead position for cardiac resynchronization: a comprehensive cinegraphic, echocardiographic, clinical, and survival analysis.
    Dong YX; Powell BD; Asirvatham SJ; Friedman PA; Rea RF; Webster TL; Brooke KL; Hodge DO; Wiste HJ; Yang YZ; Hayes DL; Cha YM
    Europace; 2012 Aug; 14(8):1139-47. PubMed ID: 22467754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using three-dimensional echocardiography to guide left ventricle lead position in cardiac resynchronization therapy: does it make any difference.
    Badran HA; Kamel JZ; Mohamed TR; Abdelhamid MA
    J Interv Card Electrophysiol; 2017 Apr; 48(3):299-306. PubMed ID: 28194611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of contractile reserve for CRT.
    Lim P; Bars C; Mitchell-Heggs L; Roiron C; Elbaz N; Hamdaoui B; Lellouche N; Dubois-Randé JL; Guéret P
    Europace; 2007 Sep; 9(9):739-43. PubMed ID: 17573360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial.
    Thébault C; Donal E; Meunier C; Gervais R; Gerritse B; Gold MR; Abraham WT; Linde C; Daubert JC;
    Eur Heart J; 2012 Nov; 33(21):2662-71. PubMed ID: 22285578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Right ventricular lead positioning does not influence the benefits of cardiac resynchronization therapy in patients with heart failure and atrial fibrillation.
    Rönn F; Kesek M; Karp K; Henein M; Jensen SM
    Europace; 2011 Dec; 13(12):1747-52. PubMed ID: 21712261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.